Related Experiment Video
Updated: Aug 6, 2026
10:37
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
Three-Dimensional Cardiac Tissue Models for Pharmaceutical Research
Xiaolu Lu1,2,3, Baoping Xie1,2, Jianing Zhong1,2
1Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (Gannan Medical University), Ministry of Education, Ganzhou, Jiangxi341000, P. R. China.
ACS Applied Bio Materials
|July 21, 2026
Summary
Three-dimensional (3D) cardiac tissue models offer a more accurate way to screen drugs for cardiovascular diseases and cardiotoxicity compared to 2D models. This advancement improves drug development efficiency and patient safety.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Drug Discovery
Background:
- Many cardiotoxic drugs are withdrawn during clinical trials, limiting cardiovascular disease treatment options.
- Current two-dimensional (2D) models inadequately represent human physiology for accurate drug screening.
- There is a critical need for improved preclinical models to assess drug efficacy and safety.
Purpose of the Study:
- To review the current landscape of three-dimensional (3D) cardiac tissue models for drug assessment.
- To evaluate the advantages, disadvantages, and applications of 3D cardiac models in cardiovascular drug research.
- To discuss the future trajectory of 3D cardiac tissue engineering in drug development.
Main Methods:
- Examination of existing literature on 3D cardiac tissue models.
- Analysis of different types of 3D cardiac models and their suitability for drug screening.
- Review of cardiovascular disease models and their application in drug research.
Main Results:
- 3D cardiac tissue models more accurately simulate human cardiac physiology than 2D models.
- These models enhance the efficiency and precision of screening for drug sensitivity and cardiotoxicity.
- Significant progress has been made in applying 3D models to cardiovascular disease research.
Conclusions:
- 3D cardiac tissue models represent a significant advancement over 2D models for drug evaluation.
- They hold great promise for improving the safety and efficacy of cardiovascular drugs.
- Future developments in 3D cardiac tissue engineering are expected to further revolutionize drug discovery.
